Van Eck Associates Corp reports 16.84% increase in ownership of NVCR / NovoCure Limited

NovoCure Limited

US ˙ NasdaqGS ˙ JE00BYSS4X48

Security	NVCR / NovoCure Limited
Institution	Van Eck Associates Corp
Latest Disclosed Ownership	25,243 shares
Latest Disclosed Value	$ 275

On May 15, 2026 - Van Eck Associates Corp filed a 13F-HR form disclosing ownership of 25,243 shares of NovoCure Limited (US:NVCR) valued at $275,149 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 21,604 shares of NovoCure Limited. The current value of the position is $407,674 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-15	2026-03-31	13F	Novocure	ORD SHS	G6674U108	25,243	3,639	16.84	0		0.0002
2026-02-13	2025-12-31	13F	Novocure	ORD SHS	G6674U108	21,604	364	1.71	0		0.0002
2025-11-13	2025-09-30	13F	Novocure	ORD SHS	G6674U108	21,240	-1,374	-6.08	0		0.0003
2025-08-14	2025-06-30	13F	Novocure	ORD SHS	G6674U108	22,614	230	1.03	0		0.0005
2025-05-15	2025-03-31	13F	Novocure	ORD SHS	G6674U108	22,384	1,325	6.29	0		0.0005
2025-01-29	2024-12-31	13F	Novocure	ORD SHS	G6674U108	21,059	-3,185	-13.14	1		0.0008
2024-10-29	2024-09-30	13F	Novocure	ORD SHS	G6674U108	24,244	376	1.58	0		0.0005
2024-07-31	2024-06-30	13F	Novocure	ORD SHS	G6674U108	23,868	8,094	51.31	0		0.0006
2024-04-30	2024-03-31	13F	Novocure	ORD SHS	G6674U108	15,774	706	4.69	0		0.0004
2024-02-05	2023-12-31	13F	Novocure	ORD SHS	G6674U108	15,068	-5	-0.03	0		0.0004
2023-11-08	2023-09-30	13F	Novocure	ORD SHS	G6674U108	15,073	959	6.79	0		0.0005
2023-08-03	2023-06-30	13F	Novocure	ORD SHS	G6674U108	14,114	-2,037	-12.61	1		0.0013
2023-05-03	2023-03-31	13F	Novocure	ORD SHS	G6674U108	16,151	-226	-1.38	1	-100.00	0.0022
2023-02-08	2022-12-31	13F	Novocure	ORD SHS	G6674U108	16,377	2,845	21.02	1	-99.90	0.0031
2022-10-27	2022-09-30	13F	Novocure	ORD SHS	G6674U108	13,532	46	0.34	1,028	9.71	0.0031
2022-08-03	2022-06-30	13F	Novocure	ORD SHS	G6674U108	13,486	-4,661	-25.68	937	-37.66	0.0025
2022-05-10	2022-03-31	13F	Novocure	ORD SHS	G6674U108	18,147	101	0.56	1,503	10.92	0.0031
2022-01-26	2021-12-31	13F	Novocure	ORD SHS	G6674U108	18,046	-1,059	-5.54	1,355	-38.94	0.0031
2021-11-03	2021-09-30	13F	Novocure	ORD SHS	G6674U108	19,105	-1,533	-7.43	2,219	-51.53	0.0056
2021-08-10	2021-06-30	13F	Novocure	ORD SHS	G6674U108	20,638	1,555	8.15	4,578	81.52	0.0108
2021-05-13	2021-03-31	13F	Novocure	ORD SHS	G6674U108	19,083	281	1.49	2,522	-22.47	0.0069
2021-02-09	2020-12-31	13F	Novocure	ORD SHS	G6674U108	18,802	-9,912	-34.52	3,253	1.78	0.0095
2020-12-04	2020-09-30	13F/A-1	Novocure	ORD SHS	G6674U108	28,714	598	2.13	3,196	91.72	0.0102
2020-11-12	2020-09-30	13F	Novocure	ORD SHS	G6674U108	28,714	598		3,196		9,908.7312
2020-08-14	2020-06-30	13F/A-1	Novocure	ORD SHS	G6674U108	28,116	243	0.87	1,667	-11.19	0.0058
2020-08-10	2020-06-30	13F	Novocure	ORD SHS	G6674U108	28,116	243		1,667		5,663.2180
2020-05-12	2020-03-31	13F	Novocure	ORD SHS	G6674U108	27,873	953	3.54	1,877	-17.28	0.0095
2020-02-13	2019-12-31	13F	Novocure	ORD SHS	G6674U108	26,920	830	3.18	2,269	16.30	0.0088
2019-11-08	2019-09-30	13F	Novocure	ORD SHS	G6674U108	26,090	88	0.34	1,951	18.67	0.0091
2019-08-07	2019-06-30	13F	Novocure	ORD SHS	G6674U108	26,002	3,111	13.59	1,644	49.05	0.0079
2019-05-13	2019-03-31	13F	Novocure	ORD SHS	G6674U108	22,891	532	2.38	1,103	47.26	0.0054
2019-02-12	2018-12-31	13F	Novocure	ORD SHS	G6674U108	22,359	3,345	17.59	749	-24.80	0.0038
2018-11-13	2018-09-30	13F	Novocure	ORD SHS	G6674U108	19,014	1,089	6.08	996	77.54	0.0049
2018-08-13	2018-06-30	13F	Novocure	ORD SHS	G6674U108	17,925	-1,227	-6.41	561	34.21	0.0026
2018-05-11	2018-03-31	13F	Novocure	ORD SHS	G6674U108	19,152	1,278	7.15	418	15.79	0.0021
2018-02-12	2017-12-31	13F	Novocure	ORD SHS	G6674U108	17,874	-1,350	-7.02	361	-5.50	0.0018
2017-11-09	2017-09-30	13F	Novocure	ORD SHS	G6674U108	19,224	858	4.67	382	20.13	0.0020
2017-08-11	2017-06-30	13F	Novocure	ORD SHS	G6674U108	18,366	18,366		318		0.0017

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.